IL93106A0 - Pharmaceutical composition for the treatment of aged skin - Google Patents

Pharmaceutical composition for the treatment of aged skin

Info

Publication number
IL93106A0
IL93106A0 IL93106A IL9310690A IL93106A0 IL 93106 A0 IL93106 A0 IL 93106A0 IL 93106 A IL93106 A IL 93106A IL 9310690 A IL9310690 A IL 9310690A IL 93106 A0 IL93106 A0 IL 93106A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical composition
aged skin
retinoic acid
skin
Prior art date
Application number
IL93106A
Other languages
English (en)
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25672393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL93106(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA 588835 external-priority patent/CA1335651C/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of IL93106A0 publication Critical patent/IL93106A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Medicinal Preparation (AREA)
IL93106A 1989-01-19 1990-01-18 Pharmaceutical composition for the treatment of aged skin IL93106A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29911989A 1989-01-19 1989-01-19
CA 588835 CA1335651C (en) 1989-01-20 1989-01-20 Method for the treatment or prevention of intrinsically aged skin with retinoids

Publications (1)

Publication Number Publication Date
IL93106A0 true IL93106A0 (en) 1990-11-05

Family

ID=25672393

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93106A IL93106A0 (en) 1989-01-19 1990-01-18 Pharmaceutical composition for the treatment of aged skin

Country Status (15)

Country Link
EP (2) EP0379367B1 (ja)
JP (1) JP2931349B2 (ja)
AT (1) ATE164513T1 (ja)
AU (1) AU636595B2 (ja)
DE (1) DE69032182T2 (ja)
DK (1) DK0379367T3 (ja)
ES (1) ES2115590T3 (ja)
FI (1) FI114968B (ja)
GR (1) GR3026573T3 (ja)
IL (1) IL93106A0 (ja)
MY (1) MY106263A (ja)
NO (1) NO900251L (ja)
PH (1) PH27578A (ja)
PT (1) PT92905B (ja)
SG (1) SG73394A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
FR2674127B1 (fr) * 1991-03-20 1993-06-11 Oreal Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine.
WO1995027474A1 (fr) 1994-04-12 1995-10-19 Kao Corporation Preparation dermatologique
EP0814799A1 (en) * 1995-03-20 1998-01-07 Allergan Use of retinoids for the manufacture of a medicament for the treatment of restenosis
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
DE69828620T2 (de) 1997-02-25 2005-12-01 The Regents Of The University Of Michigan, Ann Arbor Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut
KR20000076136A (ko) 1997-03-11 2000-12-26 스즈키 츠네시 피부 상태 개선제의 평가 방법 및 피부 외용제의 제조 방법
US6008254A (en) 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19820392A1 (de) * 1998-05-07 1999-11-11 Beiersdorf Ag Wirkstoffkombinationen enthaltende Hautpflegemittel
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
JP2002047125A (ja) * 2000-05-26 2002-02-12 Shiseido Co Ltd 皮脂分泌抑制用皮膚外用剤
JP2002284678A (ja) * 2001-03-23 2002-10-03 Ajinomoto Co Inc 皮膚外用剤
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
CA2635784C (en) 2005-12-30 2012-06-12 Revance Therapeutics, Inc. Arginine heteromers for topical administration
EP2061453B1 (en) 2006-08-16 2013-03-13 Action Medicines, S.L. 2,5-dihydroxybenzene compounds for treating cancers and hematological dyscrasias
JP5665276B2 (ja) 2008-02-27 2015-02-04 花王株式会社 皮膚老化予防又は改善剤
EP2133066A1 (en) 2008-06-13 2009-12-16 Antonio Puig, S.A. Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
US9387160B2 (en) 2008-12-22 2016-07-12 Johnson & Johnson Consumer Holdings France Composition and method of treating skin conditions
US11707442B2 (en) 2015-09-25 2023-07-25 The General Hospital Corporation Antibacterial and antifungal compounds
AU2017214615A1 (en) * 2016-02-03 2018-09-20 Galderma Research & Development Novel biaromatic propynyl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof
US10980725B2 (en) 2017-09-28 2021-04-20 Johnson & Johnson Consumer Inc. Cosmetic compositions and method of treating the skin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
FR2479819A1 (fr) * 1980-04-04 1981-10-09 Fabre Sa Pierre Le retinoate de zinc, sa preparation et les compositions topiques le contenant
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
JPS62502546A (ja) * 1985-04-22 1987-10-01 エイボン　プロダクツ　インコ−ポレイテツド しわを減少させる組成物及び方法
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
JP2606711B2 (ja) * 1986-07-16 1997-05-07 エム． クリグマン，アルバート 日光で損傷されたヒトの皮膚のレチノイドによる治療方法
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
DE3853427T2 (de) * 1987-04-06 1995-12-14 Daltex Medical Sciences Inc Behandlung gealterter haut mit oraler 13-cis-retinsäure.

Also Published As

Publication number Publication date
NO900251L (no) 1990-07-20
AU636595B2 (en) 1993-05-06
FI900293A0 (fi) 1990-01-18
FI114968B (fi) 2005-02-15
EP0815840A3 (en) 1998-03-04
GR3026573T3 (en) 1998-07-31
NO900251D0 (no) 1990-01-18
EP0815840A2 (en) 1998-01-07
ATE164513T1 (de) 1998-04-15
DE69032182T2 (de) 1998-08-20
AU4857390A (en) 1990-07-26
EP0379367A2 (en) 1990-07-25
DE69032182D1 (de) 1998-05-07
PT92905B (pt) 1995-12-29
JPH02288822A (ja) 1990-11-28
DK0379367T3 (da) 1998-10-19
SG73394A1 (en) 2000-06-20
JP2931349B2 (ja) 1999-08-09
ES2115590T3 (es) 1998-07-01
PH27578A (en) 1993-08-18
EP0379367A3 (en) 1991-04-24
PT92905A (pt) 1990-07-31
EP0379367B1 (en) 1998-04-01
MY106263A (en) 1995-04-29

Similar Documents

Publication Publication Date Title
IL93106A0 (en) Pharmaceutical composition for the treatment of aged skin
HUT63053A (en) Process for producing pharmaceutical compositions comprising 9-cis-retinoic acid
AU4876190A (en) Compositions and method for the treatment of periodontal disease
EP0303915A3 (en) Retinoids for the treatment of skin damaged by light
AU5789990A (en) Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
ATE99928T1 (de) Ester des retinols und/oder der retinsaeure enthaltende aerosol-inhalate.
AU5471190A (en) Method of topically treating acne vulgaris
CA2288706A1 (en) Use of high dose retinoids for the treatment of skin disorders
IE873478L (en) Use of 13-cis retinoic acid
EP0803247A3 (en) Skin care compositions containing a retinoid
AU6213590A (en) Fatty acid therapy
AU6255486A (en) Improvements in relation to drug treatments
MX9704948A (es) Retinoides triciclicos, metodos para su produccion y uso.
HK1004888A1 (en) Synergistic skin depigmentation composition
ES2159294T3 (es) Metodo y composicion para el tratamiento de la caida del cabello.
KR950701520A (ko) 셀레노아미노산의 경피적용에 의한 외인성 피부노화의 재생법(Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids))
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
AU7118091A (en) Pharmaceutical compositions having depigmentating and antiphotoageing activity
CA2012208A1 (en) Method of treating periodontitis
ITMI922040A1 (it) Composizioni farmaceutiche per il trattamento di stati di iperaggregabilita' piastrinica